Tel.: 615-343-3959, Fax: 615-343-6229
Infectious Causes of Cancer
Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer
Article first published online: 22 FEB 2010
Copyright © 2010 UICC
International Journal of Cancer
Volume 127, Issue 11, pages 2588–2597, 1 December 2010
How to Cite
Schneider, B. G., Peng, D.-F., Camargo, M. C., Piazuelo, M. B., Sicinschi, L. A., Mera, R., Romero-Gallo, J., Delgado, A. G., Bravo, L. E., Wilson, K. T., Peek, R. M., Correa, P. and El-Rifai, W. (2010), Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer. Int. J. Cancer, 127: 2588–2597. doi: 10.1002/ijc.25274
- Issue published online: 22 FEB 2010
- Article first published online: 22 FEB 2010
- Manuscript Accepted: 8 FEB 2010
- Manuscript Received: 22 OCT 2009
- NCRR/NIH (CTSA). Grant Number: 1 UL1 RR024975
- National Cancer Institute. Grant Numbers: P01 CA028842, R01 CA095103, R01 CA077955, R01 CA093999, P01 CA116087, P30DK058404, R01 DK053620, DK058587
- intestinal metaplasia;
Gene promoter CpG island hypermethylation is associated with Helicobacter pylori (H. pylori) infection and may be an important initiator of gastric carcinogenesis. To examine factors influencing methylation, we utilized bisulfite Pyrosequencing® technology for quantitative analysis of promoter DNA methylation in RPRM, APC, MGMT and TWIST1 genes using DNA from 86 gastric biopsies from Colombian residents of areas with high and low incidence of gastric cancer. H. pylori colonies were cultured from the same subjects, and gastric pathology was evaluated. Virulence factors cagA (including segments of the 3′ end, encoding EPIYA polymorphisms) and vacA s and m regions were characterized in the H. pylori strains. Using univariate analysis, we found significantly elevated levels of RPRM and TWIST1 promoter DNA methylation in biopsies from residents of the high-risk region compared to those from residents of the low-risk region. The presence of cagA and vacA s1m1 alleles were independently associated with elevated levels of promoter DNA methylation of RPRM and MGMT. Using multivariate analysis, DNA methylation of RPRM was associated with location of residence, cagA and vacA s1m1 status and methylation of TWIST1. We conclude that cagA and vacA virulence determinants are significantly associated with quantitative differences in promoter DNA methylation in these populations, but that other as yet undefined factors that differ between the populations may also contribute to variation in methylation status.
DNA methylation of promoter CpG islands is an important epigenetic regulatory mechanism for transcription. Methylated cytosines provide binding sites for various methyl-binding proteins, which interact with chromatin remodeling enzymes to stably repress transcription. In normal cells, repetitive elements are inactivated by DNA methylation, while the CpG islands of many housekeeping genes are protected from methylation. Conversely, in cancer cells, repetitive elements lose their methylation, and CpG islands in many promoters become aberrantly methylated. Inactivation of tumor suppressor genes by promoter hypermethylation is considered to be an important contributor to carcinogenesis.1
Gastric cancer is responsible for ∼800,000 deaths, annually worldwide,2 and the majority of these occur in the developing world. Infection with Helicobacter pylori (H. pylori) is the major environmental risk factor for gastric cancer.3 However, identification of H. pylori infection alone as a risk factor does not simplify the problem of gastric cancer prevention, because approximately half of the world's population is infected. Most of these persons will have only gastritis, and less than 1% will develop cancer. Global eradication of the infection by antibiotic use is impractical, due to cost and to the problem of generation of antibiotic-resistant strains of H. pylori and other pathogenic bacteria. Homo sapiens and H. pylori have coevolved over millennia, and the infection may produce some benefits for the host, such as reduced rates of asthma and lower risk of esophageal diseases.4–6 Therefore, identification of more accurate biomarkers for increased risk of gastric cancer could be beneficial in reducing the burden of mortality from this disease.
H. pylori strains vary in their ability to induce and promote gastric cancer. Among the well-established virulence factors is cagA, a marker for a pathogenicity island carried by some strains.7, 8 This gene encodes the CagA protein, which is injected into gastric epithelial cells by the type IV Cag secretion system of H. pylori. Once within the cell, CagA becomes tyrosine phosphorylated by Abl and Src family kinases, and then is able to bind to Src Homology 2-containing tyrosine phosphatase (SHP-2) and disrupt cell signaling.9 Numerous studies have found an association between the presence of CagA in infecting strains and gastric cancer risk.10 Among CagA positive strains, some variants are associated with an even greater risk for gastric cancer. CagA is polymorphic, containing 3 or more EPIYA (Glu-Pro-Ile-Tyr-Ala) motifs within its C-terminus. Among Western H. pylori strains, those with more than 3 EPIYA motifs have greater affinity for SHP-2 and disrupt epithelial cell morphology in vitro.11 Notably, persons infected with strains bearing CagA proteins with more than 3 EPIYA motifs are at a greater risk for gastric cancer than those harboring strains bearing only 3 motifs.12 We previously reported that in Colombian populations, persons infected with CagA positive strains with more than 3 EPIYA motifs have more severe gastric precancerous lesions.13
Another important H. pylori virulence factor is vacA, which encodes the vacuolating cytotoxin. This gene is also polymorphic: the sequence encoding the signal peptide is either s1 (with s1a, s1b and s1c subtypes), or s2; the middle portion of the gene is found as m1 or m2 alleles. Strains bearing vacA s1m1 alleles produce more toxin and are associated with more severe pathology than those bearing s2m2 alleles.14
Recent reports indicate that infection with H. pylori is associated with elevated levels of aberrant DNA methylation. Chan et al. found the presence of aberrant methylation of the CDH1 promoter to be associated with the presence of H. pylori in gastric mucosae of dyspeptic patients.15 Maekita et al. quantitatively examined methylation levels within promoters of LOX, HAND1, THBD, HRASLS, FLNC, ARC and CDKN2A (p16), and found increased methylation in DNAs from H. pylori-infected subjects compared to uninfected individuals.16 Additional affected gene promoters have been identified, including TWIST117–19 Leung et al. found a lower methylation density at the CDH1 promoter after H. pylori eradication,20 and an independent study examining H. pylori-associated promoter methylation in 5 genes (CDH1, p16, MLH1, APC and COX2) similarly reported that aberrant methylation was significantly reduced or completely eliminated 1 year after H. pylori eradication.21 Elevated methylation levels of the FLNC and CDKN2A (p16) genes in gastric mucosae of H. pylori-infected subjects have also been associated with elevated risk for gastric cancer.22, 23
We aimed to determine whether DNA methylation differences could be detected within the context of H. pylori infection in 2 populations in Colombia. Although situated only 143 miles apart, these 2 populations differ in gastric cancer incidence by approximately 25-fold (150 vs. 6 per 100,000).24 The high-risk region is in the rural Andes mountain villages, where the population is supported by agriculture. This population is of mixed Amerindian and Spanish extraction. The low-risk region is along the Pacific coast, where the economy is based on fishing. This population is of mixed African and Spanish ancestry. By 5 years of age, 80% of the children in both populations are infected with H. pylori, and infection is acquired at a rate that does not differ significantly between the 2 populations.25 The high-risk population has an elevated proportion of subjects infected with more virulent H. pylori strains (CagA positive, vacA s1m1), but this difference is estimated at 24% or less.26, 27 These populations provide a useful natural laboratory in which to examine risk factors and potential biomarkers for gastric cancer.
Material and Methods
The study population consisted of 86 men with dyspeptic symptoms, aged 31–60 years, who underwent upper endoscopy in gastroenterology clinics in 2 public hospitals between June and September, 2006. Ethics committees of the participating hospitals and of the Universidad del Valle in Cali, Columbia, approved the protocol for our study, and all patients provided informed consent. The subjects were residents of Tuquerres in the Andes Mountains and Tumaco on the Pacific Coast, both in the State of Nariño, Columbia. Exclusion criteria for the study were serious chronic diseases, previous gastrectomy or ingestion of proton pump inhibitors, H2-receptor antagonists or antimicrobials in the month prior to the endoscopy. Biopsy samples from the antrum (greater curvature, within 5 cm of the pylorus), incisura angularis (lesser curvature) and corpus (middle anterior wall) were obtained by a single experienced gastroenterologist. One biopsy from each site was fixed in buffered formalin and embedded in paraffin for histopathology. One biopsy from the gastric antrum was frozen in glycerol and thioglycolate for culture of H. pylori organisms. Another biopsy, from the antrum, was frozen without any added solution, for analysis of DNA methylation. Frozen biopsies were shipped on dry ice to Vanderbilt University in Nashville, TN, and were stored at −80°C until thawed for culture or methylation analysis.
Four-micron sections were stained with hematoxylin and eosin for the diagnosis performed independently by 2 experienced pathologists (MBP and PC). Discordant diagnoses were reviewed until a consensus was reached. Diagnosis was performed by established guidelines as normal, nonatrophic gastritis (NAG), multifocal atrophic gastritis without intestinal metaplasia (MAG), intestinal metaplasia (IM) or dysplasia (DYS).28, 29 Pathologists evaluated diagnoses blinded to residence of subjects.
H. pylori culture and genotyping
One antral and 1 corpus biopsy per person were homogenized under sterile conditions and cultured on selective Trypticase soy agar with 5% sheep blood and vancomycin (20 μg/ml), bacitracin (200 μg/ml), nalidixic acid (10 μg/ml) and amphotericin B (2 μg/ml), (all from Sigma, St Louis, MO), as previously described.13 Small gray translucent colonies characteristic of H. pylori appeared after 4 to 8 days. Identity of H. pylori was confirmed by morphology, Gram stains and assays for oxidase and urease. Pellets from 3 single colonies per biopsy were frozen for analysis. DNA was isolated with either a Puregene kit (Qiagen, Valencia, CA) or by proteinase K digestion overnight followed by phenol/chloroform extraction. In preliminary experiments, 2–5 colonies per person were analyzed from 28 subjects by DNA fingerprinting analysis to evaluate the frequency of mixed infections in the colonies harvested from the antral and corpus biopsies.30 In all 28 subjects, all colonies from the same person produced identical DNA amplification patterns, indicating that there were no mixed infections in the strains harvested from a single individual. Subsequently, all analyses for H. pylori virulence markers were performed on DNA from a single colony per subject, isolated from the antral biopsy.
DNA from 1 colony per participant was genotyped for cagA and vacA s and m regions. Analysis of cagA, including the polymorphic 3′ end, was previously described from H. pylori strains from our study population.13 The vacA s region of each strain was amplified by primers VA1F14 and Vac785 (R: AATACGCTCCCACGTATTGC), using an annealing temperature of 52°C. Polymerase chain reaction (PCR) products were treated with ExoSAP-IT (USB, Cleveland, OH) and sequenced using BigDye 3.1 terminator chemistry with an ABI 3130xl Genetic Analyzer. Two strains were genotyped for the vacA s region by PCR alone, using primers VA1F and VA1R14 followed by electrophoresis in a 1.5% agarose gel, discriminating a 259 bp fragment for s1 or a 286 bp fragment for s2. The vacA m region was defined by multiplex PCR using primers M1F2, M1R2, M2F1 and M2R1.31 Primer sequences and details of amplifications are described in Sicinschi et al.27
We used a Pyrosequencing® technique, which allows independent quantitative determination of methylation at selected CpG sites in the gene promoter. To obtain material for the analyses, gastric antral biopsies, 1 intact biopsy per person, were homogenized using disposable plastic pestles and digested overnight with proteinase K. DNA was isolated by phenol/chloroform extraction and quantitated with a Nanodrop instrument (Thermo Scientific, Wilmington, DE); 0.5–2 μg of DNA per biopsy was bisulfite modified, using a Zymo EZ Methylation Direct kit (Zymo Research Corp., Orange, CA). Modified DNA (20 ng per reaction) was amplified by PCR, using 0.2 μM of each primer, 2 units of hot start Taq DNA polymerase, and 0.2 mM of each deoxynucleotide triphosphate (dNTP) per reaction. Primer sequences and their location are listed in Table 1. Cycling programs were 95°C for 15 min., then 48 cycles of 95°C for 30 sec, 55°C for 30 sec, and 72°C for 30 sec, followed by a 5-min incubation at 72°C. PCR products were examined following gel electrophoresis in 1.5% agarose, to confirm that a single band was obtained. In preparation for Pyrosequencing, the biotinylated strand of each PCR product was isolated from 10 to 20 μl of each PCR product using a Vacuum Prep Tool (Qiagen), according to the manufacturer's protocol. Pyrosequencing reactions were performed in a PyroMark MD Pyrosequencing instrument (Qiagen), in the presence of 500 nM sequencing primer, following the manufacturer's recommendations. The positive control for methylation was methylated HeLa DNA (New England Biolabs, Ipswich, MA); the negative control was normal human blood DNA (Promega Corp., Madison, WI). Positive and negative controls were run with each experiment. Pyrosequencing assays contained a control for incomplete bisulfite modification. Methylation values used for analysis were the mean of the percent methylation measured for the first 3 potential methylation sites following the sequencing primer.
Age, histological diagnoses, levels of methylation at the 4 gene promoters, H. pylori virulence genes and number of EPIYA motifs were compared in a univariate fashion by risk area using χ2, Fisher's exact, Wilcoxon/Mann Whitney, Spearman and Student's t tests, as appropriate. Mathematical transformations of the 4 levels of methylation were evaluated to reduce data skewness. H. pylori status was analyzed several ways combining cagA and vacA genotyping. To assess the degree to which various factors explained levels of methylation, multivariate generalized linear models were used. For continuous and binary variables, the coefficients represent the average difference in percentage of methylation for a 1-unit change in the predictor (i.e., for every year of age or low- vs. high-risk area). In the case of H. pylori genotypes, the coefficient represents the average difference in percentage of methylation associated with being a part of the specified category (cagA and vacA s1m1 or other genotypes) as compared to the reference group (uninfected). Diagnosis was considered as an ordinal variable (0 = Normal/NAG, 1 = MAG and 2 = IM/DYS), for purposes of estimating the p-values in the test of linear trend (p-trend).
Regression analyses were individually applied to original and mathematically transformed variables. As the results were similar, only those results based on the original variables are presented. Data were analyzed using the software package Stata 10.0 (Stata Corporation, College Station, TX). Prism 5.0b (GraphPad Software, La Jolla, CA) was used to generate Figure 1.
A kappa coefficient of reliability was run on 64 replicates to assess reproducibility of the Pyrosequencing results. This analysis produced a kappa statistic of 0.29 (95% CI = 0.27–0.37, bias corrected), with complete agreement of 31% of samples, a standard error of 0.023 and a correlation coefficient of 0.983 (p < 0.0001).
Subjects and their infecting H. pylori strains
Table 2 shows the description of the subjects from the high- and low-risk populations and their infecting H. pylori strains. Age distributions and prevalence of H. pylori infection were similar in the 2 groups, but the high-risk population had more advanced gastric precancerous lesions (p = 0.021). Among the 64 strains that were analyzed for vacA s region by sequencing, all were s1b. Among the cagA positive strains, most had EPIYA patterns of ABC (66% of the cagA positive strains from the low-risk region, and 57% of those from the high-risk region). This difference was not significant. Of the remaining cagA positive strains, most were ABCC, but some variants were found: an AC strain in the low-risk region, and 1 each of ABCCC, ABBCC, ABBC, ABCBC and BCC in the high-risk region.13
In univariate analysis, levels of methylation (either medians or means) in the RPRM and TWIST1 promoters were significantly associated with the area of residence of the subject, with more methylation being found in the DNA from subjects in the high-risk area. No significant difference was detected for the APC or MGMT promoters.
Considering results from the entire set of DNA samples, generalized unadjusted linear regression models showed that levels of methylation in the RPRM and MGMT promoters were positively and significantly associated with histological diagnoses (coefficient: 2.1; p-trend = 0.018 for RPRM; coefficient: 3.0; p-trend = 0.003 for MGMT). Coefficients indicate that as lesions progressed, higher levels of methylation were observed. In the small number of uninfected patients, median percent methylation was 8% for RPRM (n = 4), 38% for APC (n = 3), 39% for MGMT (n = 4) and 6.5% for TWIST1 (n = 4). Regarding H. pylori infection, the presence of cagA and vacA s1m1 alleles was associated with elevated levels of methylation of RPRM and MGMT. Interestingly, the association with APC was inverse, such that more virulent H. pylori strains were associated with less methylation of this gene. Age was not associated with levels of methylation.
Multivariate regression models incorporated effects of geographic area, diagnosis, age and genotypes of the infecting H. pylori strain (classified as uninfected, cagA positive, vacA s1m1 and all other genotypes; Table 3). Because alternative grouping of variables of H. pylori status, including numbers of EPIYA motifs, or analysis by the presence of cagA alone, did not improve the explanatory capacity of the models and led to similar results, parsimonious models with the highest adjusted R2 (coefficient of determination) are presented. In these models, the observed mean differences between area and RPRM or TWIST1 remained statistically significant, as did the differences between H. pylori virulence genes and RPRM, MGMT or APC. Adjustment for covariates significantly attenuated the differences between histological diagnoses and levels of methylation of RPRM and MGMT. Age did not have any significant effect on the levels of methylation.
Because significant correlations exist between TWIST1 (correlation coefficient ρ = 0.58; p < 0.001) and MGMT (ρ = 0.39; p = 0.001) with RPRM, the combined effect of methylation in these genes was simultaneously evaluated in a regression model using methylation of RPRM as outcome and including the covariates from the multivariate model. When TWIST1 and MGMT were included as covariates, TWIST1 was significantly associated with RPRM (coefficient, 1.04; p < 0.0001) and MGMT showed a trend toward significance (Coefficient, 0.14; p = 0.078). All effects were independent, as there was no significant interaction or effect modification between any of the covariates in the multivariate model.
An interesting outlier
One biopsy from a resident of the high-risk region was a notable outlier. DNA from this biopsy showed elevated methylation at all the 4 regions examined, for RPRM (55% methylation, compared to a median of 21%, 95% CI: 19–23%), for TWIST1 (38% methylation, compared to a median of 10%, 95% CI: 8–11%), for APC (37%, compared to a median of 23%, 95% CI: 22–27%) and MGMT (73%, compared to a median of 58%, 95% CI: 55–61%; Fig. 1). Histopathological analysis of paraffin-embedded biopsies of the same subject showed extensive intestinal metaplasia in all 3 sites examined (antrum, corpus and incisura angularis) and focal areas of indefinite dysplasia in antrum and corpus.
In an attempt to understand mechanisms that regulate progression toward gastric cancer, we compared 2 populations that differ greatly in the incidence of this disease, although they have equally high prevalence of H. pylori infection.26, 27 As expected, the 2 populations differed in diagnosis, with more severe lesions occurring more frequently in the high-risk region. We detected a trend for the presence of the more virulent cagA positive, vacA s1m1 strains more often in the high-risk region, consistent with our findings in prior studies with different subjects from these populations.26, 27 The quantitative method used to measure DNA methylation allowed us to detect differences in levels of methylation previously missed by earlier methods, such as methylation-specific PCR, which reveals only that methylation is present, without quantitating it. In our study, low levels of methylation present in uninfected patients could be measured; this methylation may occur due to environmental stressors not examined in our analysis. Univariate analysis comparing methylation levels of tissues representing the 2 populations showed differences in methylation of 2 genes: RPRM and TWIST1. When we examined several possible covariates of methylation, using multivariate analysis, geographic area remained as an independent effect, with more methylation in RPRM and TWIST1 in the high-risk region.
Because many epidemiological studies have shown an association of cagA and vacA s1m1 with gastric cancer risk, we sought to determine if these virulence factors were associated with promoter methylation in the 4 genes examined. For RPRM and MGMT, an independent effect of cagA and vacA s1m1 on methylation levels was detected. In contrast, for APC, decreased levels of promoter methylation were associated with more virulent H. pylori genotypes. Unadjusted analyses showed that levels of methylation in the RPRM and MGMT promoters were significantly associated with the histological diagnoses, but adjustment for genotypes of the infecting H. pylori strains significantly attenuated the associations. This attenuation is likely due to the association between H. pylori infection and diagnosis of more severe lesions. Our study also demonstrated differential methylation of RPRM and TWIST1 promoters by geographic area, even after adjustment for histological diagnosis and virulence determinants. These results indicate that other virulence determinants of the infecting strains are likely to be responsible for those differences, and/or that additional features distinguishing the 2 populations, such as diet or genetic features of the host, are important in differentiating risk.
In a prior examination of promoter methylation status and H. pylori virulence determinants, Watanabe et al. examined methylation of MINT25, RORA, GDNF, ADAM23, PRDM5 and MLF1 in gastric washings from Korean subjects with and without gastric cancer.32 These investigators tested for the presence of cagA in infecting strains and found no association with methylation. A difference from our study, besides the ethnicity of the subjects, is that Watanabe et al. assayed cagA by PCR on DNA from gastric washings, in contrast to our method of PCR using DNA from cultured bacteria. Culture is likely to be a more sensitive method for detection of H. pylori and its virulence determinants. In addition, as gastric lesions become more advanced, H. pylori infection is often lost, so that evaluation of H. pylori and its virulence determinants in gastric cancers may under-represent the infection originally present.33 Thus, our study on premalignant lesions may have been more likely to detect infections originally present.
Park et al. examined methylation levels in a set of genes by quantitative methods, comparing premalignant gastric tissues and gastric cancers, with and without H. pylori infection,34 and found significant differences between infected and uninfected subjects, in the DNA samples from gastritis, but not from intestinal metaplasia, adenomas or gastric cancers. While some studies have found H. pylori-related methylation to be associated with age,19, 35 others,15, 36 including the current study, have found no significant associations. However, the age range of our subjects was 29 years, and it is possible that with a broader age range, a significant association might be detected.
The genes we chose to study have been previously noted to be associated with development of gastric cancer. One such gene was RPRM, a p53-dependent mediator of the G2/M cell cycle checkpoint.37RPRM is a tumor suppressor, which is inactivated by promoter methylation in a variety of human tumors, including gastric adenocarcinoma.38 Notably, RPRM promoter methylation has been reported in premalignant conditions such as Barrett's esophagus39 and nonmalignant gastric epithelia.38 Aberrant methylation of RPRM may be detected by methylation-specific PCR (MSP) in plasma of gastric cancer patients, in contrast to plasma of control subjects, suggesting the potential of RPRM as a biomarker for early gastric cancer.40 Our results also support the identification of this gene as one that may be altered early in the progression toward gastric cancer.
Another gene we examined was the APC (adenomatous polyposis coli) gene, which encodes a component of a multiprotein complex that inactivates β-catenin in the Wnt signaling pathway. A critical tumor suppressor in the gastrointestinal tract, APC is expressed in the stomach as 2 isoforms originating from promoters 1A and 1B.41 Methylation in gastric tissue occurs predominantly in promoter 1A, and for this reason, this promoter is frequently examined in studies of hypermethylation in gastric cancer.42, 43 However, in contrast to the colon, methylation at promoter 1A in gastric mucosae is not predominantly tumor related, but is frequently found in non-malignant gastric mucosae,44 as we also observed. Promoter 1B is not methylated, and gene expression studies have shown that transcription of APC in the stomach is regulated primarily from this promoter.44, 45 Consequently methylation at promoter 1A in gastric mucosae is likely to be a passenger, rather than a driver of carcinogenesis. Among the 4 genes we examined, after adjustment for diagnosis, it is notable that only the APC promoter showed a decrease in methylation in DNAs from subjects from the high-risk region.
MGMT encodes O-6-methylguanine-DNA methyltransferase (also called O-6-alkylguanine-DNA alkyltransferase), a DNA repair enzyme that removes alkylation adducts from guanine. MGMT must be constantly renewed, as part of defense against mutagens. MGMT promoter hypermethylation is associated with a wide variety of tumors, including gastric cancers.46 Our assays detected a relatively high level of MGMT promoter methylation in most of the gastric biopsies. Additional studies will be necessary to determine how these elevated levels are related to MGMT gene expression.
TWIST1 encodes a basic-helix–loop-helix transcription factor called Twist1 that regulates metastasis47 and epithelial-to-mesenchymal transition.48 Twist1 represses transcription of E-cadherin and TIMP1 (an inhibitor of matrix metalloproteinases)49 and promotes migration in neoplastic cells.50, 51 Although the Twist1 protein may have tumor- or metastasis-promoting effects, paradoxically, hypermethylated TWIST1 is reported in cancers of the stomach and other tumor types.48, 52 All of our Colombian subjects, with the exception of 1 outlier, had relatively low levels of TWIST1 hypermethylation.
Limitations of our study include the fact that we examined DNA from biopsies containing premalignant lesions, instead of DNA from gastric cancers. Our goal was to investigate early events in gastric carcinogenesis, and not all these events may lead to cancer. Another limitation is the use of entire biopsies for our DNA preparation, so that mixed cell types are included. Although most of the cells contributing DNA were gastric epithelial cells, other cells including stromal and inflammatory cells may have contributed to the differences in methylation levels that we measured. Additional studies employing microdissection will be useful to confirm identity of the cell type demonstrating alterations in methylation levels.
A topic of intense investigation is the mechanism(s) by which promoter methylation becomes dysregulated during the development of cancer, and how inflammation may promote this process. In our study, we found that 2 of the 4 genes we examined (RPRM and TWIST1) increased together in levels of methylation, and a third (MGMT) trended toward such an increase, consistent with a common or related mechanism affecting most of the genes we studied. Results from an outlier subject, whose biopsy showed high or remarkably elevated promoter methylation in all 4 genes examined, are consistent with the existence of a global methylation defect that can occur early in the stages of carcinogenesis. Although this widespread hypermethylation was observed in only 1 subject, we expect progression of H. pylori-related disease to occur in only a small minority of infected persons, and therefore events occurring within the gastric mucosae of these rare individuals provoke great interest. Analysis of DNA methylation of additional genes and the effect of that methylation on gene transcription will be necessary to clarify early events in H. pylori-related gastric cancer development.
The mechanisms by which virulent H. pylori infection may influence promoter hypermethylation remain obscure, but several hypotheses which involve enhancement of DNA methyltransferase activity have been proposed. H. pylori infection promotes gastric epithelial cell proliferation and increased production of epidermal growth factor (EGF) and its receptor53; the EGF receptor has greater activity with the more virulent cagA positive strains.54 EGF administered to gastric epithelial cells in culture increases DNA methyltransferase activity.55
Another possible mechanism by which H. pylori can promote hypermethylation involves the effect of nitric oxide on DNA methyltransferase. Katayama et al. noted that the RUNX3 gene promoter in the human gastric cancer cell line MKN45 can become methylated by coculture with H. pylori and macrophages, and this effect can be replicated by substituting nitric oxide (NO) for the bacteria and macrophages.56 Inhibition of NO synthesis in the coculture reversed the methylation. Hmadcha et al. reported that treatment of an insulinoma cell line by IL-1β or NO could inactivate the FMR1 and HPRT genes by hypermethylation.57 This effect was apparently mediated by enhancement of DNA methyltransferase activity, without an increase in transcription of the methyltransferase gene.
In conclusion, RPRM and TWIST1 promoter DNA methylation were found to be elevated in gastric biopsies from residents of the high-risk region compared to those from residents of the low-risk region in Colombia. Virulence genes cagA and vacA s1m1 in the infecting H. pylori strains were independently associated with elevated levels of methylation of RPRM and MGMT. Alterations in DNA methylation are early changes in the progression of premalignant lesions and have the potential to serve as biomarkers for gastric cancer risk.
The authors wish to acknowledge Ms. Jacki Huckins (Qiagen) for assistance in assay design for the RPRM Pyrosequencing assay. The content presented here is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.
- 2Global Cancer Facts & Figures 2007. Atlanta, GA: American Cancer Society, 2007., , , , , , .
- 5cagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus. Am J Gastroenterol 2000; 95: 2206–11., , , , , , , , .Direct Link:
- 21Aberrant DNA methylation in non-neoplastic gastric mucosa of H. pylori infected patients and effect of eradication. Am J Gastroenterol 2007; 102: 1361–71., , , , , , , , .Direct Link:
- 26Virulence-associated genotypes of Helicobacter pylori: do they explain the African enigma? Am J Gastroenterol 2002; 97: 2839–2842., , , .Direct Link: